12:00 AM
Jun 23, 2014
 |  BC Week In Review  |  Company News  |  Deals

Medivir, Beactica deal

Beactica will identify novel hits against an undisclosed “disease-relevant protease of...

Read the full 35 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >